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Abstract 
Background: CD24 is a cell adhesion molecule that has been implicated in metastatic tumor progression cells. 
Our aim was to clarify the correlation between CD24 expression and cAMP:cGMP ratio in murine colorectal 
cancer cell line (CT26) after using cholera toxin. 
Materials and Methods: The CT26 cells were cultured in flasks for assaying cAMP and cGMP by ELISA kits; 
also the cells were cultured in flasks for assaying cytoplasmic and membranous CD24 expression. The Real-Time 
PCR was done for cDNA that was synthesized from CT26 cells’ mRNA. Also, expression CD24 marker of cells 
was determined by Anti-CD24 antibody and Goat Anti-Rabbit IgG-FITC (flow cytometry).  
Results: The cholera toxin increases the cAMP:cGMP ratio and  influenced the cytoplasmic and membrane CD24 
expression level.  
Conclusion: Cholera toxin increased cAMP. After increasing cAMP/cGMP ratio, cytoplasmic and membranous 
CD24 expression showed decline. 
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Introduction 
The third most common cause of death in the world is 
colorectal cancer (CRC) 1. In 2008, about 608,700 
deaths from CRC and 1.2 million new cases had been 
reported throughout the world. Australia, New 
Zealand, Europe and North America have the highest 
incidences; whereas Africa, South-Central Asia have 
the lowest incidence rates 2. There are acceptable 
methods for screening and detecting CRC, including 
occulted blood in feces, flexible sigmoidoscopy, 
double-contrast enema and colonoscopy 3.  
There are several markers like CD24, CD44, CD133 
and CD166 on the surface of cells of different tumors 
such as breast, lung, colorectal, pancreas, prostate, 
ovarian and renal 4. CD24 is a single chain 
sialoglycoprotein with 24 KD molecular weights 5. 
CD24 and clinicopathological factors have correlation 
with the degree of differentiation 6. It is expressed in a 
large variety of malignancies 7. CD24 is a ligand for P-
selectin which can disseminate CD24 positive tumor 
cells 8.  
Cyclic 3’, 5’-adenosine monophosphate (cAMP) and 
Cyclic 3’,5’-guanosine monophosphate (cGMP) are 
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intracellular second messengers. They mediate the 
action of large numbers of hormones and 
neurotransmitters 9. The cGMP in some tissues acts 
opposite of cAMP; thus, increase of cGMP 
concentration is associated with cell proliferation but 
increasing level of cAMP inhibits cell proliferation 10, 
11. cAMP and/or cGMP level alterations had been 
reported in tissues, blood and urine of patients with 
cancers and other pathophysiological states 12, 13.  
Cholera toxin (CT) belongs to the family of AB5 
bacterial toxins. The total molecular mass of the 
holotoxin, AB5, is 86 KDa. The A subunit (28 kDa) of 
CT is composed of two distinct parts A1 and A2. The 
A1 component is responsible for the toxic enzyme 
activity, while the A2 component serves as non-
covalent linker of subunit A to subunit B (58.4 KDa). 
Then subunit A1 is translocated to the cytosol of the 
host cell, where it catalyses the covalent transfer of an 
ADP-ribose moiety of the signaling protein Gsα. 
Ribosylated form of Gs stabilizes the GTP bound of 
protein, which stays continually activated. This 
modification of the adenylate cyclase system results in 
an elevated level of cAMP which causes the activation 
of the sodium pumps in the lumen of the cells. The 
electrochemical imbalance is then compensated by 
driving Cl- and H2O out of the cells. The process of 
Cholera Toxin action is followed by enormous loss of 
water from the epithelial cells into the intestinal lumen, 
causing water diarrhea characteristic for cholera 14. 
Our aim in this study is showing that cytoplasmic and 
membranous CD24 expression affected by increasing 
cAMP:cGMP ratio. 
Methods 
Cholera toxin (CT): Toxin was isolated from Vibrio 
cholerae (Inaba) PTCC1611 that is toxigenic without 
protease production. This strain was purchased from 
Iranian Research Organization for Science and 
Technology.  
Cell line: CT26 is an undifferentiated murine 
colorectal adenocarcinoma cell line that was purchased 
from Pasteur Institute of Iran (Tehran). 
Bacterial culture: Large amount of CT was produced 
in 500 ml of Modified YEP medium (yeast extract 
0.4%, Bactopepton 1%, NaCl 0.5%, KCl 0.15% and 
sodium bicarbonate 0.4%; PH 7.0) at 37ºC for about 20 
h on a rotary shaker at 90 rpm 15, 16. The toxin was 
separated from cells by Millipore Stericup filter PVDF 
membrane (0.22 μm, Sigma Co.). Then it was 
concentrated by using a 30 KD Amicon Ultra 
Centrifugal filter. The toxin confirmation by Anti-
Cholera toxin antibody (Abcam Co.) was followed by 
semi-dry western blot method. In addition, the toxin 
concentration was assayed by PRO-MEASUR Protein 
Measurement Solution (iNtRON Co, Korea). 
Appropriate concentration of cholera toxin was 
determined by MTT 17.  
cAMP and cGMP assay: CT26 cell line was 
inoculated in two tissue culture flasks (vent 25 cm2, Jet 
Biofil Co.), 7 ml RPMI GlutaMAX, HEPES (Gibco 
Co.) + 10% FBS (Invitrogen Co.) were added and cells 
were incubated at 37ºC in 5% CO2, until filling of about 
80% of flasks. 10 ng/ml of cholera toxin was added in 
one of the flasks and was returned to incubate for 36 h. 
The cells were separated by scrapers and were poured 
in separate falcon tubes. The tubes were centrifuged in 
12000g for 10 min. The supernatants were used for 
cAMP and cGMP assay by cAMP direct immunoassay 
and cGMP direct immunoassay kits (Abcam Co.) 
according to company protocols. The OD of wells was 
read at wave length 450 by ELISA reader (BioTek).  
mRNA extraction: RNA extraction from toxin 
affected and non-toxin affected cells was done by easy-
BLUE Total RNA Extraction Kit (iNtRON Co.) and 
two groups cDNAs were constructed by Maxime RT 
PreMix Kit [Oligo (dt)15 Primer] (iNtRON Co.). The 
program was 45ºC for 60 min and 95 ºC for 5 min (36 
cycles). 
Real-time PCR: Amplification primers for CD24 were 
5’- TACCCACGCAGAT TTACTG -3’ (Forward) and 
5’- CAGTAGAGATGTAGAAGAG -3’ (Reverse) and 
for GAPDH as a housekeeping gene were 5’- 
ATGATGACATCAAGAAGG TG -3’ (Forward) and 
5’- AGTTGCTGTTGAAGTCGCAG -3’ (Reverse). 
The RT-PCR reactions were done in 0.2 μl: 12.5 μl 
Power SYBR Green PCR Master Mix (Invitrogen Co.) 
+ 1µl forward primer + 1µl reverse primer + 3 µl 
cDNA + 7.5 µl DDW (Table 1). 
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Table 1: The Real Time-PCR for cytoplasmic CD24 
Time (min or 
sec) 
Temperature (ºC) Steps No. 
5 min 94 Initial denaturation 1 
45 Sec 94 Denaturation 2 
45 Sec 52 Annealing 3 
45 Sec 72 Extension/elongation 4 
10 min 72 Final elongation 5 
Short-term 4 Hold 6 
Stages 2-5, 35 cycles 7 
 
Flow cytometry: Dissociated cells (with and without 
cholera toxin) with Trypsin/ EDTA (Sigma Co.) were 
counted and each group transferred to a 5 ml tube. The 
cells were washed twice with PBS containing 2% FBS 
each time they were centrifuged at 4ºC for 5 min (1500 
rpm). Then cells were re-suspended in cold PBS with 
2% FBS; for each cell group (106 cells/ml), 100μl were 
transferred to microtubes. 1μg/ml Anti-CD24 
antibodies (Abcam Co.) as a first antibody were added 
to each tube and were incubated for 15 min on ice. The 
cells were washed 3 times with cold PBS containing 
2% FBS and after each time, they were centrifuged at 
400 rpm for 5 min. The pellets were re-suspended in 
cold PBS with 2% FBS and 1μg/ml Goat Anti-Rabbit 
IgG-FITC (Abcam Co.) as a second antibody was 
added to each tube; they were incubated for 15 min on 
ice. Excess antibody was washed with cold PBS 
containing 2% FBS in 1500 rpm for 5 min. The cells 
were re-suspended with cold PBS 1X and flow 
cytometry was done using Bench-Top Flow Cytometry 
(Partec PAS III, Germany). 
Statistical analysis: Statistically significant difference 
was determined by Chi square (ϰ2) analysis and 
definition as p˂0. 05. In addition, the correlation 
between cAMP:cGMP ratio and CD24 expression were 
determined by the Pearson correlation coefficient. 
Also, results of RT-PCR and flow cytometry were 
analyzed by REST V2.0.13 and FlwJo V10.0.6 
softwares, respectively. 
Results 
The MTT assay (data are not shown) confirmed that10 
ng/ml of cholera toxin could transform fibroblasts 
CT26 cell line after 36 h (Figure 1). After 36 hours, the 
cAMP level was significantly higher in CT26 cell 
culture with toxin than cell culture without toxin 
(p=0.04), 8 pmol VS. 9.2 pmol, respectively. However, 
the cGMP level showed a bit elevation in CT26 with 
toxin, but this increasing was not significant (p=0.1). In 
addition, cAMP:cGMP ratio had no significant excess 
against cholera toxin (p=0.1) (Table2).  
 
Figure 1:  Cholera toxin transformed CT26: a) CT26 culture 
without toxin; b) CT26 culture with toxin after 24 h; c) ) CT26 
culture with toxin after 36 h 
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CT: Cholera toxin; cAMP: Cyclic adenosine monophosphate; cGMP: 
Cyclic guanosine monophosphate 
 
Cytoplasmic CD24 changes were assessed by RT-PCR. 
The cytoplasmic CD24 expression showed significant 
decrease in cell culture with toxin against control cell 
culture (p=0.00). Also, the flow cytometry for CD24 
expression level (CD24low+ and CD24high+) on cell 
surface displayed a significant decline in cell culture 
with toxin in comparison with control cell culture 
(p=0.0001) (Figure 2). Albeit, in Q3 area (Figure 2) 
there was a development in CD24high+ expression on 
cells.  
The CD24 expression in cytoplasm and on cell surface 
had strong indirect correlation with cAMP:cGMP ratio 
(r = -1). 
 
 
Figure 2: a) Decreasing cytoplasm CD24 expression in cultured 
CT26 with toxin; b) Flow cytometry of cultured CT26 without toxin; 
c) Flow cytometry of cultured CT26 with toxin 
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Discussion 
In our study, the cAMP level in cultured CT26 cells 
without and with cholera toxin had increased to 8 and 
9.2 pmol, but cGMP displayed decline to 5.8 and 4.2. 
The cAMP/cGMP in cell group was higher than 
cultured CT26 with toxin. In addition, increasing 
cAMP/cGMP ratio was in parallel with the cell 
morphology transformation. These results were similar 
to above studies. In Zhu study the cholera toxin (CT) in 
10 ng/ml concentration can induce morphological 
transformation in glioma cells 17. CT accumulates 
cAMP with ADP-ribosylation of Gs protein18. 
Increasing cAMP is the cause of glioma cell 
differentiation19,  20.  
In our study, MTT assay confirmed that 10 ng/ml of 
cholera toxin could transform CT26 cell line. The 
cyclic nucleotide (cAMP and cGMP) metabolism 
alterations has often been found in neoplastic tissues 21. 
The plasma cAMP/cGMP in the normal subjects and 
the acute leukemia patients were 3.56 pmol/ml and 
1.51 pmol/ml, respectively 22. Another study showed 
that urinary level cAMP/cGMP in normal subjects (7 
μmol/24h) is higher than abnormal cervical cytology 
(1.4 μmol/24h) 12. In rats with hepatoma, tumor size 
was correlated with cGMP level; it was decreased after 
chemotherapy, radiotherapy and surgery. Plasma 
cGMP levels in patients with cirrhosis are significantly 
higher than control subjects. In the cirrhotic patients’ 
plasma cGMP/cAMP ratio levels were significantly 
higher than control group 23. Deregulation of cAMP 
and cGMP pathways occur during infection, intestinal 
inflammation and cancer 13. 
In our study, the cytoplasmic CD24 expression had a 
significant decline when CT26 cell line was cultured 
with cholera toxin (p= 0.00). Also, identical result was 
seen for membranous CD24 (p= 0.0001). A small 
population of cells was converted to CD24 high+. CD24 
as an alternative ligand of P-selectin and an adhesion 
receptor on activated endothelial cells and platelets can 
enhance the metastatic potential of CD24 expressing 
tumor cells 24, 25. In the gastric cancer (NUGC-2) and 
colonic cancer (COLO-2001) cell lines, CD24 
expression was detected in RNA blot analysis 26. CD24 
is an import marker for cancer diagnosis and prognosis. 
CD24 expression is significantly higher in invasive 
breast carcinoma than in precancerous lesions. Cell-
surface and cytoplasmic CD24 expression correlates 
with poor prognosis, histology grades, tumor sizes and 
lymph node positivity 27, 28. In Weichert study, the 
normal colon mucosa was negative for CD24, although 
some cases displayed a weak membranous staining in 
the brush border; but the CD24 expression in colorectal 
carcinomas was high. Membranous CD24 staining was 
positive in 68.7% of tumors and strongly positive in 
17% of tumors. For cytoplasmic CD24 staining, 84.4% 
of cases were positive and 10.2% cases showing a 
strong expression. Cytoplasmic CD24 was significantly 
associated with higher tumor stages, nodal or systemic 
metastasis, and finally tumor grade. The strong 
cytoplasmic CD24 expression is associated with 
shortened patient survival times, which shows the 
biological role of CD24 in colorectal cancer 29.  
Furthermore, cytoplasmic and membranous CD24 had 
strong indirect correlate with cAMP:cGMP ratio (r = -
1). Similar study was not found to compare with our 
study. 
Conclusion 
cAMP level and cAMP:cGMP ratio in cultured cells 
with cholera toxin were higher than control cells. In 
CT26 cell line, cytoplasmic and membranous CD24 
expression declined after using cholera toxin. In 
addition, There was an indirect correlation between 
cAMP:cGMP excess and decrease in CD24 expression. 
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